Home > News > OTC Stock Review
July 19th, 2005
OTC Stock Review
Abstract:
Shares of BIPH closed at $2.65 on Monday on volume of 683,343 shares. Our recent alert adding BIPH to our watch list indicated that April 4, 2005, three months before Boston Scientific paid a premium to buy $5 million worth of Biophan's shares, Beacon Equity Research issued a report with a price target of $5.17
Source:
primezone.com
Related News Press |
Announcements
Sensors innovations for smart lithium-based batteries: advancements, opportunities, and potential challenges August 8th, 2025
Deciphering local microstrain-induced optimization of asymmetric Fe single atomic sites for efficient oxygen reduction August 8th, 2025
Japan launches fully domestically produced quantum computer: Expo visitors to experience quantum computing firsthand August 8th, 2025
ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials August 8th, 2025
Financial Reports
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |